PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX
Portfolio Pulse from
Kahn Swick & Foti, LLC has announced a lead plaintiff deadline of March 14, 2025, for a class action lawsuit against Pacira BioSciences, Inc. Investors who purchased securities between August 2, 2023, and August 8, 2024, and incurred losses over $100,000 are encouraged to apply.
January 28, 2025 | 2:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences is facing a class action lawsuit with a lead plaintiff deadline of March 14, 2025. The lawsuit pertains to securities purchased between August 2, 2023, and August 8, 2024, with losses exceeding $100,000.
The announcement of a class action lawsuit can negatively impact investor sentiment and stock price in the short term. The lawsuit involves significant financial losses, which may lead to increased volatility and potential sell-offs.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100